Mesalamine Controlled-Release Capsules and Tocilizumab (Intravenous)
Determining the interaction of Mesalamine Controlled-Release Capsules and Tocilizumab (Intravenous) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: tocilizumab
Brand name: Actemra, Actemra ACTPen
Synonyms: Tocilizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Controlled-Release Capsules-Tocilizumab Auto-Injectors
- Mesalamine Controlled-Release Capsules-Tocilizumab Prefilled Syringes
- Mesalamine Controlled-Release Capsules-Todays Health Nasal Relief Extra Moisturizing
- Mesalamine Controlled-Release Capsules-Tofacitinib
- Mesalamine Controlled-Release Capsules-Tofacitinib Citrate
- Mesalamine Controlled-Release Capsules-Tofacitinib Extended-Release Tablets
- Tocilizumab (Intravenous)-Mesalamine Delayed Release Tablets
- Tocilizumab (Intravenous)-Mesalamine Long-Acting Capsules (Apriso)
- Tocilizumab (Intravenous)-Mesalamine Long-Acting Capsules (Delzicol)
- Tocilizumab (Intravenous)-Mesalamine Long-Acting Capsules (Pentasa)
- Tocilizumab (Intravenous)-Mesalamine rectal
- Tocilizumab (Intravenous)-Mesalamine Rectal Enema